IGMS logo

IGM Biosciences (IGMS) Company Overview

Profile

Full Name:

IGM Biosciences, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

September 18, 2019

Indexes:

Not included

Description:

IGM Biosciences, Inc. is an American biopharmaceutical company specializing in the discovery and development of new drugs based on the engineering of IgM antibodies (antibodies naturally produced by the human immune system) for the treatment of oncological diseases. The company has been in operation since 1993 and is based in Mountain View, California. Candidate drugs: IGM-2323 IgM antibody targeting T-cells for the treatment of patients with non-Hodgkin's lymphoma. IGM-8444 and IGM-7354 antibodies being investigated for the treatment of patients with solid and hematologic malignancies. The company has developed and patented its own technological platform for antibody engineering. Additionally, the company is conducting preclinical studies of drugs for the treatment of acute myeloid leukemia and multiple myeloma.

Events Calendar

Earnings

Next earnings date:

Mar 7, 2025

Recent quarterly earnings:

Nov 8, 2024

Recent annual earnings:

Mar 7, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 13, 25 JP Morgan
Neutral
Jan 10, 25 Truist Securities
Hold
Jan 10, 25 Stifel
Hold
Jan 10, 25 RBC Capital
Sector Perform
Jan 10, 25 Jefferies
Hold
Jan 10, 25 BMO Capital
Market Perform
Dec 6, 24 BMO Capital
Outperform
Nov 11, 24 Stifel
Buy
Oct 18, 24 RBC Capital
Outperform
Oct 1, 24 Wedbush
Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for IGM Biosciences?
  • Does IGM Biosciences pay dividends?
  • What sector is IGM Biosciences in?
  • What industry is IGM Biosciences in?
  • What country is IGM Biosciences based in?
  • When did IGM Biosciences go public?
  • Is IGM Biosciences in the S&P 500?
  • Is IGM Biosciences in the NASDAQ 100?
  • Is IGM Biosciences in the Dow Jones?
  • When was IGM Biosciences's last earnings report?
  • When does IGM Biosciences report earnings?
  • Should I buy IGM Biosciences stock now?

What is the ticker symbol for IGM Biosciences?

The ticker symbol for IGM Biosciences is NASDAQ:IGMS

Does IGM Biosciences pay dividends?

No, IGM Biosciences does not pay dividends

What sector is IGM Biosciences in?

IGM Biosciences is in the Healthcare sector

What industry is IGM Biosciences in?

IGM Biosciences is in the Biotechnology industry

What country is IGM Biosciences based in?

IGM Biosciences is headquartered in United States

When did IGM Biosciences go public?

IGM Biosciences's initial public offering (IPO) was on September 18, 2019

Is IGM Biosciences in the S&P 500?

No, IGM Biosciences is not included in the S&P 500 index

Is IGM Biosciences in the NASDAQ 100?

No, IGM Biosciences is not included in the NASDAQ 100 index

Is IGM Biosciences in the Dow Jones?

No, IGM Biosciences is not included in the Dow Jones index

When was IGM Biosciences's last earnings report?

IGM Biosciences's most recent earnings report was on Nov 8, 2024

When does IGM Biosciences report earnings?

The next expected earnings date for IGM Biosciences is Mar 7, 2025

Should I buy IGM Biosciences stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions